Back to homepage

Tag "urinary tract symptoms"

Experience with ospemifene in patients with vulvar and vaginal atrophy and urinary incontinence: case studies

Authors: Zuramis Estrada Blanco MD, Mariella Lilue MD, Santiago Palacios MD, PhD

The two case studies presented in this article support the findings from a series of retrospective studies, which showed that urinary symptoms improved in women with overactive bladder syndrome who were receiving ospemifene for vulvovaginal atrophy (VVA), a component of genitourinary syndrome of menopause.